Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scinomix is a U.S.-based laboratory automation company serving life science and adjacent laboratory markets with automated sample management and labeling systems. The company designs and manufactures equipment for tube, vial, and microplate labeling, handling, barcode scanning, capping, and related workflow automation used in clinical, pharmaceutical, biotechnology, forensic, agricultural, and genetic testing labs. Its product portfolio includes automated tube and plate labeling systems such as the Sci-Print line, along with custom automation and integration capabilities. In January 2026, Scinomix was acquired by Ingersoll Rand and joined the Life Sciences platform within Ingersoll Rand’s Precision and Science Technologies segment. The business is not a therapeutics developer; it is a commercial provider of lab automation hardware and workflow solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scinomix.